Health
Experimental ALS drug shows potential to prolong patient survival – News-Medical.Net
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s…
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) and Amylyx Pharmaceuticals, Inc., the company that manufactu…
-
Noosa News12 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News10 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News5 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car
-
General23 hours agoCatholic Education Tasmania to close six schools, with three others partially closed, due to coloured sand recall